Sizzling interest in lab-grown meat belies lack of basic research
Elie Dolgin • February 6, 2019
'Clean meat’ firms have drawn tens of millions of dollars in investment in recent years, but technical hurdles remain.
Private investment in lab-grown meat is soaring as companies chase the promise of boundless — and delicious — nuggets, steaks and burgers cultured in vitro rather than reared on the hoof.
Continue reading here.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.